Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
The company recently received CEP certificate approval for Losartan Potassium by EDQM
Revenue from Operations stood at Rs. 2,607 crore, 25% YoY growth. Domestic revenue at Rs. 2,400 crore, 20% YoY growth and export revenue at Rs. 207 crore, 118% YoY growth
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
The company has secured two orders for male condoms from CMSS worth Rs. 9.65 crores and Rs. 6.58 crores respectively
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries
Lack of technology transfer stands out as a formidable barrier
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
Subscribe To Our Newsletter & Stay Updated
